Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
about
Primary cutaneous lymphomas: diagnosis and treatmentT-cell lymphomas, a challenging disease: types, treatments, and future.Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsDiverse cutaneous manifestations associated with a single disease.Treatment of mycosis fungoides: overview.Treatment of mycosis fungoides/Sezary syndrome: the University of California, San Francisco (UCSF) approach.Management of the primary cutaneous lymphomas.Treatment of patch-stage mycosis fungoides with topical corticosteroids.Management with topical nitrogen mustard in mycosis fungoides.Emerging drugs in cutaneous T-cell lymphomas.Hypopigmented mycosis fungoides in type v skin: a report of 5 cases.Emerging treatment options for early mycosis fungoides.Menus for managing patients with cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma in sub-Saharan Africa.Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach.Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.Treatment algorithms for mature T-cell and natural killer-cell neoplasms.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.Cutaneous T cell lymphoma: update on treatment.Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.Topical corticosteroid-induced skin atrophy: a comprehensive review.Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphomaMycosis fungoides: therapeutic difficulties.Hypopigmented mycosis fungoides: a 20-case retrospective series.Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.Neoplasms
P2860
Q26772207-9C0F79DE-8366-4DF4-9867-8321C6C7ED1CQ30244553-F6705FBF-AFA2-4760-9D23-D08AAAC0C049Q30252152-B32E1D9B-F252-4055-9F57-7DCBA75D876FQ33746059-2E910D14-1998-4FDF-8190-B166E85B03F5Q34116799-71FAB086-D03B-468B-8CE7-655CABC58F0CQ34574172-C8DD9478-CF13-4602-BFCA-1A3E6AB477C8Q35064399-774DAC32-8828-4C97-ACD5-BE2DAABF04ADQ35583232-85ADDD8B-82B1-465E-A11E-DA4D245E856AQ35612014-335126CC-D481-4CE7-BC03-52758626D6EFQ35612016-8287A98D-8D4D-4B9D-8ED5-54D2B767C662Q36150634-A9BF86D9-D1B4-485E-956C-9AE417056369Q36417554-CFA136DC-00B1-4E8A-B578-A93400725D68Q36635567-0D80A2B7-A38C-4B05-94CE-D21D5E31F56FQ36934406-FBC67D62-F264-46A9-B55E-0444C90CA17AQ37398969-34463AD0-8AF3-4041-B6F0-E45F12E27201Q37444717-88ACE6C4-032D-41B0-A643-AF3782D53978Q37810272-0C1BA484-E910-4E1D-B6C9-3CD8E199E0C0Q37932546-95790403-106E-480C-9D04-BDEA2400A28EQ37944565-E20075FA-D5AE-4BEF-88B8-499DCC8CFB22Q37981969-4D727825-E36F-4C46-81FE-E444F1DCCFBFQ37998019-B9D576A9-63C1-4ACB-B8A0-2FD056007656Q38036396-1B6CD9D7-0854-4353-B8F2-711B91DFAD45Q38212880-CEC1112C-C70B-4A66-8EEB-258A56E107EEQ38415302-B81F1020-DA6C-46F4-81AC-E229C63B049BQ39955238-71DB484C-738D-4A9C-A562-4DE861F4F342Q42665053-5DB56C78-BF7D-4F06-8E1B-7E3737AE618FQ48273894-F80E8A21-9670-4614-9745-C2F728439D72Q53635286-8B8A20C8-77CE-4380-87C5-0FDAC2FEBB61Q56828372-47B32ABB-61CF-4A5B-8296-0762BB890EFA
P2860
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@en
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@nl
type
label
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@en
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@nl
prefLabel
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@en
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@nl
P2093
P1433
P1476
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
@en
P2093
Kashani-Sabet M
Zackheim HS
P304
P356
10.1001/ARCHDERM.134.8.949
P577
1998-08-01T00:00:00Z